Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 22, 2020

SELL
$220.06 - $304.07 $42.1 Million - $58.1 Million
-191,217 Closed
0 $0
Q3 2019

Oct 29, 2019

SELL
$217.44 - $243.88 $13.5 Million - $15.1 Million
-62,114 Reduced 24.52%
191,217 $44.5 Million
Q2 2019

Jul 17, 2019

SELL
$219.29 - $241.72 $10.7 Million - $11.8 Million
-48,676 Reduced 16.12%
253,331 $59.2 Million
Q1 2019

Apr 18, 2019

SELL
$216.71 - $338.96 $789,041 - $1.23 Million
-3,641 Reduced 1.19%
302,007 $71.4 Million
Q4 2018

Jan 14, 2019

BUY
$278.5 - $352.75 $417,193 - $528,419
1,498 Added 0.49%
305,648 $92 Million
Q3 2018

Oct 04, 2018

SELL
$293.51 - $383.83 $6.6 Million - $8.63 Million
-22,482 Reduced 6.88%
304,150 $107 Million
Q2 2018

Aug 22, 2018

BUY
$257.52 - $306.91 $84 Million - $100 Million
326,342 Added 112531.72%
326,632 $0
Q2 2018

Aug 21, 2018

SELL
$257.52 - $306.91 $76.6 Million - $91.3 Million
-297,517 Reduced 99.9%
290 $327,000
Q1 2018

Apr 06, 2018

BUY
$260.13 - $367.91 $2.03 Million - $2.87 Million
7,791 Added 2.69%
297,807 $81.5 Million
Q4 2017

Jan 10, 2018

BUY
$307.64 - $344.58 $5.36 Million - $6 Million
17,414 Added 6.39%
290,016 $92.4 Million
Q3 2017

Oct 12, 2017

BUY
$281.15 - $329.69 $76.6 Million - $89.9 Million
272,602
272,602 $85.4 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Waverton Investment Management LTD Portfolio

Follow Waverton Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waverton Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Waverton Investment Management LTD with notifications on news.